Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.
about
Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacycGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Phosphodiesterase type 5 inhibitors: back and forward from cardiac indicationsClinical and molecular genetics of the phosphodiesterases (PDEs).Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ionsCombined effect of sildenafil and guanethidine, propranolol or verapamil on erectile function in rats.Daily use of sildenafil 50mg at night effectively ameliorates nocturia in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: an exploratory multicenter, double-blind, randomized, placebo-controlled study.PDE-5 and NOS II mRNA expression in menopausal women: a molecular biology study.The effect of phosphodiesterase-5 inhibitor, tadalafil, on potassium chloride-induced contractions of isolated human ureteral tissue
P2860
Q33624262-A6F49DAA-685A-450E-8642-584BA27DE52AQ34129318-7FAB64C2-AC83-4E6F-9CB1-782B9201C615Q34244951-D733FFF0-7959-4430-BDD9-FAA10DE799D1Q36460566-11F0DB17-0045-4EF4-9042-711BDDAC646CQ37657841-8F5FAD5F-8918-4BA9-AC70-B182972A8D04Q37947681-B87651DF-7FDA-4F83-8509-F204EBA820EBQ41873056-74008D0B-946E-4085-80C1-8E8E866FEE9DQ42650059-8104E112-5515-4393-9F81-A47535DF6806Q46244505-3102BEC9-54A3-4A46-B57A-FE6FFEC21D48Q47559071-B29456B1-4EA5-4839-9340-392164392018Q51581882-ECAB021D-A176-48E6-9723-BBA82EA499BCQ58593623-3980E630-8B97-4EEE-B629-F96D35B80009
P2860
Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms that coul ...... to improve erectile function.
@en
Molecular mechanisms that coul ...... to improve erectile function.
@nl
type
label
Molecular mechanisms that coul ...... to improve erectile function.
@en
Molecular mechanisms that coul ...... to improve erectile function.
@nl
prefLabel
Molecular mechanisms that coul ...... to improve erectile function.
@en
Molecular mechanisms that coul ...... to improve erectile function.
@nl
P2093
P2860
P356
P1476
Molecular mechanisms that coul ...... to improve erectile function.
@en
P2093
G Z Morris
J D Corbin
S H Francis
P2860
P2888
P304
P356
10.1038/IJIR.2008.4
P577
2008-04-17T00:00:00Z